Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Efficacy and Safety of Antibiotic Therapeutic Drug Monitoring (TDM) in Patients With Difficult-to-Treat Gram-Negative Bacterial (DT-GNB) Infections

NCT05942157 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.

NCT NCT05942157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05942157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Efficacy and Safety of Antibiotic Therapeutic Drug Monitoring (TDM) in Patients With Difficult-to-Treat Gram-Negative Bacterial (DT-GNB) Infections
Lead sponsor
Singapore General Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 29, 2023
Completion date
December 31, 2025
Enrollment
810 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antimicrobial resistance, bacterial infections, hemodynamic instability, sepsis, therapeutic drug monitoring